Product Information
ACETAMINOPHEN-IBUPROFEN 250-125 MG CAPLET is a generic product labeled by Rugby Laboratories, priced at $0.0844 per EA under NDC 00536137636. Its NADAC has been published 115 times since Mar 20, 2024.
The Low Outlier badge above means this manufacturer's average price in the Acetaminophen and Ibuprofen market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250; 125 mg/1; mg/1
Manufacturer
Rugby LaboratoriesNDC
00536137636
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
5/20/2026
Active Ingredients
ACETAMINOPHEN; IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA216592On Market Since
7/15/2023
Pharmacological Classes
Price Statistics
The NADAC for ACETAMINOPHEN-IBUPROFEN 250-125 MG CAPLET has been published 115 times since Mar 20, 2024, and over the history we have for it it has risen 33.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0844 per EA |
|---|---|
| All-time high | $0.1086 (Jul 16, 2025) |
| All-time low | $0.0610 (May 22, 2024) |
| 52-week high | $0.1086 |
| 52-week low | $0.0839 |
| Median price | $0.0892 |
| Average price | $0.0856 |
| Largest weekly change | +15.2% (Jul 17, 2024) |
| Weeks tracked | 115 |
| Tracking since | Mar 20, 2024 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN-IBUPROFEN 250-125 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN-IBUPROFEN 250-125 MG CAPLET, manufactured by Rugby Laboratories, is $0.0844 per EA (NDC 00536137636), effective May 27, 2026.
How has the price of ACETAMINOPHEN-IBUPROFEN 250-125 MG CAPLET changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN-IBUPROFEN 250-125 MG CAPLET has risen 33.9%. It has been tracked across 115 weekly CMS publications since Mar 20, 2024.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN-IBUPROFEN 250-125 MG CAPLET?
Since Mar 20, 2024, the NADAC for ACETAMINOPHEN-IBUPROFEN 250-125 MG CAPLET has ranged from a low of $0.0610 (May 22, 2024) to a high of $0.1086 (Jul 16, 2025), with a median of $0.0892 per EA.
Are there cheaper alternatives to ACETAMINOPHEN-IBUPROFEN 250-125 MG CAPLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as ACETAMINOPHEN-IBUPROFEN 250-125 MG CAPLET, but none are currently priced below it.
Who manufactures ACETAMINOPHEN-IBUPROFEN 250-125 MG CAPLET?
ACETAMINOPHEN-IBUPROFEN 250-125 MG CAPLET (NDC 00536137636) is labeled by Rugby Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification